Michael Sarcone
Stock Analyst at Jefferies
(0.16)
# 4,902
Out of 5,182 analysts
10
Total ratings
25%
Success rate
-23.55%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Hold | $81 → $66 | $55.07 | +19.85% | 2 | Feb 12, 2026 | |
| AXGN Axogen | Maintains: Buy | $29 → $36 | $39.39 | -8.61% | 2 | Dec 4, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $184.70 | -24.20% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $3.22 | -37.89% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $24.09 | +294.35% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $122.07 | +2.40% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $6.79 | +47.33% | 1 | Mar 21, 2023 |
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $81 → $66
Current: $55.07
Upside: +19.85%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $39.39
Upside: -8.61%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $184.70
Upside: -24.20%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $3.22
Upside: -37.89%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $24.09
Upside: +294.35%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $122.07
Upside: +2.40%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $6.79
Upside: +47.33%